Compare Organon Pharma Indonesia Tbk. (SCPI) vs Unilever Indonesia Tbk. (UNVR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Unilever Indonesia Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Unilever Indonesia Tbk. trades at Rp1,630 (market cap 63.14T, 16.73M 24h volume). The key difference: Unilever Indonesia Tbk. is far larger — about 604.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | UNVR | |
|---|---|---|
Market Cap | 104.4B | 63.14T |
Volume | — | 16.73M |
Lot | — | 167.33K |
Turnover | — | 27.33B |
Average Price | — | 1,633.14 |
Value | — | 27.33B |
Indicative Equilibrium Price | — | 1,630 |
Indicative Equilibrium Volume | — | 6.97K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Unilever Indonesia Tbk.
PT Unilever Indonesia Tbk (the Company) was established on 5 December 1933 as Levers Zeepfabrieken N.V. by deed No. 23 of Mr. A.H. van Ophuijsen, a notary in Batavia, which was approved by the Gouverneur Generaal van Nederlandsch-Indie in letter No. 14 on 16 December 1933, registered at the Raad van Justitie in Batavia under No. 302 on 22 December 1933 and published in the Javasche Courant on 9 January 1934, Supplement No. 3.
Read more on UNVR →
